Related Experiment Video
Updated: May 4, 2026

Reproductive Techniques for Ovarian Monitoring and Control in Amphibians
Published on: May 12, 2019
Two new 17 α-hydroxyprogesterone transformation products fromNocardia DSM 43298.
S Choudhry1, S Halos, D Krischenowski
1Centre for Advanced Molecular Biology, University of the Punjab, Quaid-I-Azam Campus, 54590, Lahore, Pakistan.
Two novel steroid compounds were identified as transformation products of 17 α-hydroxyprogesterone using Nocardia DSM 43298. Spectroscopic analysis confirmed the structures of these new seco-steroids.
Area of Science:
- Microbiology
- Organic Chemistry
- Biochemistry
Background:
- 17 α-hydroxyprogesterone is a key steroid hormone precursor.
- Microbial transformation is a significant pathway for steroid modification.
- Nocardia species are known for their metabolic capabilities.
Purpose of the Study:
- To isolate and characterize novel transformation products of 17 α-hydroxyprogesterone.
- To investigate the microbial metabolism of steroids by Nocardia DSM 43298.
Main Methods:
- Isolation of transformation products from Nocardia DSM 43298 cultures.
- Structure elucidation using advanced spectroscopic techniques (e.g., NMR, Mass Spectrometry).
Main Results:
- Two new seco-steroid compounds were successfully isolated.
- The structures were identified as 9,10-seco-1,3,5(10)-pregnatrien-3,17 a-dihydroxy-9,20-dione and 9,10-seco-1,3,5(10)-pregnatrien-3,17a,20-triol-9-one.
- These compounds are direct transformation products of 17 α-hydroxyprogesterone.
Conclusions:
- Nocardia DSM 43298 metabolizes 17 α-hydroxyprogesterone to unique seco-steroid structures.
- This study expands the known microbial transformations of progesterone derivatives.
- The identified compounds may have potential applications in steroid chemistry or drug discovery.
More Related Videos
09:26Cellular Lipid Extraction for Targeted Stable Isotope Dilution Liquid Chromatography-Mass Spectrometry Analysis
Published on: November 17, 2011
14:03High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
Published on: March 24, 2023